Weight Gain: A Possible Side Effect of All Antiretrovirals

Weight gain and body mass index (BMI) increase are central issues in patients living with HIV who need to minimize the risk of metabolic disease. Information collected through the SCOLTA cohort revealed significant 1-year BMI increase in patients treated with dolutegravir (P = .004), raltegravir (P...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Forum Infect Dis
Autors principals: Taramasso, Lucia, Ricci, Elena, Menzaghi, Barbara, Orofino, Giancarlo, Passerini, Simone, Madeddu, Giordano, Martinelli, Canio Vito, De Socio, Giuseppe Vittorio, Squillace, Nicola, Rusconi, Stefano, Bonfanti, Paolo, Di Biagio, Antonio
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5727459/
https://ncbi.nlm.nih.gov/pubmed/29255735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx239
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars